Targeted lung cancer drug shows promise in phase I/II clinical trial
Targeted lung cancer drug shows promise in phase I/II clinical [...]
Targeted lung cancer drug shows promise in phase I/II clinical [...]
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and [...]
Experimental drug to treat liver cancer shows evidence of [...]
Test Press release Lorem ipsum dolor sit amet, [...]